Vascular Boot Market Forecast and CAGR
According to the latest research by Fact.MR, Vascular boot market is set to witness a 5.5% growth during the year 2021-2031. The market is expected to witness growth owing to an increase in demand for vascular boots which offer complete and accurate offloading of the heels along with it naturally warms up the limb. Vascular boots are used by various interventionalists and surgeons.
What is Driving Demand for Vascular Boot Market?
Primary factor driving the growth of the vascular boot market is its various benefits which provide quick and easy support to the users. Total offloading is offered along with complete floating of the heel and layers. No pressure points are present in the vascular boots. Furthermore, it is properly insulated to improve the warmth level of the limb. Vascular boot devices consist of foot drop prevention wings which are removable in nature.
Moreover, vascular boot devices do not consist of natural rubber latex due to which it provides enhanced comfort level to the patients.
Vascular Boot Prevents Heels Ulcer due to this Advantageous Benefit; Vascular Boot Device Market is likely to Augment over the Forecast Period
Vascular boot is basically used on patients on arterial thrombolytics, undergoing intra-aortic pump procedures (IABP) along with post -BKA contralateral foot. Vascular boot is majorly used to prevent heel ulcers also foot drop.
Furthermore, it is also used for patients suffering from cold mottled feet, diabetic neuropathy, pressure related injuries, spinal cord injury, peripheral vascular disease and many more. Therefore, such advantageous benefit provided by vascular boot devices augment the market growth over the forecast period.
The US and Canada Vascular Boot Market Outlook
Rising prevalence and awareness about various injuries such as cold mottled feet, diabetic neuropathy, pressure related injuries, spinal cord injury, peripheral vascular disease and many more, together with increasing healthcare expenditure is boosting the market growth.
Moreover, extensive R&D activities and effort by key players to develop cost-effective and advanced vascular boots are acting as major growth drivers in the U.S. market. Similarly, manufacturers are coming up with point-of-care devices due to a shifting trend towards patient-self-testing, which is further expected to supplement the growth of the market during the forecast period.
Moreover, technological advancements in case of vascular boot devices are likely to augment the market growth.
Europe Demand Outlook for Vascular Boot Market
Europe would witness the highest growth after North America due to the rising prevalence of the vascular related injuries in the region. According to the World Health Organization, in the European region, numerous types of heels related issues affect more than 50 million children and adults.
Cold molted feet is one of the most commonly reported diseases which is mainly affecting young people, contribute strongly to vascular injuries and lost productivity in Europe and result into increased the healthcare burden in Europe. Thus the government is taking the initiative to create awareness among the people to use vascular devices to reduce the healthcare burden.
Increasing government initiative and increasing incidences of vascular related issues in the region is expected to drive Vascular boot market in Europe.
Who are the Key Manufacturers and Suppliers of Vascular Boot Market?
Some of the leading manufacturers and suppliers of Vascular boot market Testing include Medtronic (Ireland), Becton, Boston Scientific Corporation (US), Biosensors International Group (Singapore), Abbott (US), iVascular (Spain), Cardinal Health (US), Dickinson and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), and BIOTRONIK SE & Co. KG (Germany)
The Vascular boot market is fragmented with the availability of different global and regional manufacturers. Increasing focus on research and development to launch safe and effective vascular boot treatment owing to the growing need for treatment of heel related issues would explore opportunities for the manufacturers in the vascular devices market. Acquisitions and mergers and expansion of product portfolios are the strategies adopted by these companies to increase market share.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
By Product Type
- Angioplasty Balloons
- Angioplasty Stents
- EVAR Stent Grafts
- Other Devices
- Vascular Closure Devices
- Introducer Sheaths
- Balloon Inflation Devices
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa